From a “Forgotten Experiment” in the 1960s to today: Clinical Preprints in the Light of History

Post by ASAPbio Fellow Aleksandra Petelski The usage of preprints in the clinical world is drastically increasing, especially during the current COVID-19 pandemic. In this rapidly developing situation, medRxiv already received over 8,000 preprints (and counting) involving COVID-19 at the current time of writing [1].  The use of preprints as a means for science dissemination…

Clinician’s Corner: How might preprints benefit sharing clinical trial results?

Blog post by ASAPbio Fellow Suraj Kannan The recent emergence of preprints in clinical research (most prominently through medRxiv) has raised a number of questions about their potential for benefit/harm. Preprints and preprint servers have existed in various basic and hard science disciplines for the past several decades, and have improved speed of dissemination and…

Welcome to Clinician’s Corner

A series aimed at opening the dialogue surrounding preprint usage in the clinical community. Run by the ASAPbio Fellows Vanessa Bortoluzzi, Kirsty Ferguson, Suraj Kannan and Aleksandra Petelski. Today, scientific discovery moves at a faster pace than even a decade ago [1]. However, the publishing process required by journals does not seem able to keep…